cerdulatinib small molecule sykjak kinase inhibitor development treatment hematological lowest nm values fms developed portola pharmaceuticals september fda granted orphan drug status cerdulatinib treatment peripheral tcell lymphoma httpsenwikipediaorgwikicerdulatinib